C反应蛋白/白蛋白比值联合血小板计数与格拉斯哥昏迷评分对热射病患者预后的评估价值
该研究回顾性分析南充市中心医院ICU 2020年5月1日至2023年10月31日收治的73例热射病患者,按28天预后分为存活组41例与死亡组32例,比较入院时各项指标。多因素Logistic回归显示GCS评分(OR=0.686,95%CI 0.491-0.959,P=0.028)、PLT(OR=0.973,95%CI 0.954-0.992,P=0.005)、NEU(OR=1.312,95%CI 1.072-1.606,P=0.009)和CRP/Alb比值(OR=7.652,95%CI 1.632-35.881,P=0.010)是28天死亡的独立影响因素。ROC曲线显示GCS、PLT、CRP/Alb单独预测28天预后的AUC分别为0.705、0.752、0.729,三者联合预测AUC最高为0.917,敏感度86.2%、特异度81.2%。作者认为三者联合对热射病预后有较高的预测价值。
要点
- 热射病死亡组入院GCS 7.0(5.0, 8.0)低于存活组8.5(7.0, 11.0),GCS每升高1分28天死亡OR=0.686(95%CI 0.491-0.959,P=0.028)。
- 死亡组PLT 107.00(73.50, 126.00)×10⁹/L低于存活组131.50(107.50, 176.25)×10⁹/L,PLT的OR=0.973(95%CI 0.954-0.992,P=0.005)。
- 死亡组CRP/Alb比值0.53(0.08, 1.77)高于存活组0.08(0.02, 0.44),CRP/Alb比值OR=7.652(95%CI 1.632-35.881,P=0.010)。
- 死亡组NEU 13.05(8.56, 15.67)×10⁹/L高于存活组9.50(6.68, 12.09)×10⁹/L,NEU的OR=1.312(95%CI 1.072-1.606,P=0.009)。
- GCS、PLT、CRP/Alb单独预测AUC分别为0.705、0.752、0.729,三者联合AUC 0.917,敏感度86.2%、特异度81.2%。
适用人群与场景
- 南充市中心医院ICU 2020年5月1日至2023年10月31日收治的热射病患者73例,其中28天存活41例、死亡32例。
- 不同预后两组性别与年龄差异无统计学意义。
研究设计与关键结果
- 研究类型为回顾性分析,纳入73例热射病患者,28天存活41例、死亡32例。
- 死亡组WBC 14.80(11.44, 17.15)×10⁹/L vs 存活组11.96(9.47, 14.82)×10⁹/L,NEU 13.05(8.56, 15.67)×10⁹/L vs 9.50(6.68, 12.09)×10⁹/L,AST 108.00(52.70, 291.50)U/L vs 64.50(38.25, 110.50)U/L,ALT 62.00(19.50, 159.00)U/L vs 34.50(20.75, 70.75)U/L,CRP 22.49(3.42, 58.93)mg/L vs 3.68(1.01, 11.46)mg/L,CRP/Alb比值0.53(0.08, 1.77)vs 0.08(0.02, 0.44),均P<0.05。
- 死亡组入院GCS 7.0(5.0, 8.0)vs 存活组8.5(7.0, 11.0),PLT 107.00(73.50, 126.00)×10⁹/L vs 131.50(107.50, 176.25)×10⁹/L,TBil 15.60(10.00, 25.30)mmol/L vs 21.40(14.80, 30.05)mmol/L,Alb 32.65(32.53, 49.30)g/L vs 38.70(36.20, 40.40)g/L,均P<0.05。
- 多因素Logistic回归:GCS评分OR=0.686(95%CI 0.491-0.959,P=0.028)、PLT OR=0.973(95%CI 0.954-0.992,P=0.005)、NEU OR=1.312(95%CI 1.072-1.606,P=0.009)、CRP/Alb比值OR=7.652(95%CI 1.632-35.881,P=0.010)。
- ROC曲线:GCS、PLT、CRP/Alb单独预测28天预后的AUC分别为0.705、0.752、0.729;三者联合AUC最高为0.917,敏感度86.2%、特异度81.2%。
证据类型、等级与局限
- 证据类型:回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为CRP/Alb比值、PLT、GCS评分均是影响热射病患者预后的独立影响因素,对预后均有一定预测价值,其中三者联合对热射病预后有较高的预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the prognostic value of C-reactive protein (CRP)/albumin (Alb) ratio combined with platelet count (PLT) and Glasgow coma score (GCS) in patients with heat stroke (HS).
METHODS: A retrospective analysis was conducted on the clinical data of HS patients admitted to the department of intensive care unit (ICU) of Nanchong Central Hospital from May 1, 2020 to October 31, 2023. This included general information, admission GCS, laboratory indicators and 28-day prognosis. The differences in the above indicators were compared between two groups of patients with different prognoses. Statistically significant indicators from univariate analysis were included in multivariate Logistic regression analysis to screen for factors influencing 28-day mortality in HS patients. The predictive value of various influencing factors on the 28 days prognosis of HS patients were analyzed by receiver operator characteristic curve (ROC curve).
RESULTS: A total of 73 HS patients were included, of whom 41 survived for 28-day and 32 died. There were no statistically significant differences in gender and age between the two groups of HS patients with different prognoses. The white blood cell count (WBC), neutrophil count (NEU), aspartate aminotransferase (AST), alanine aminotransferase (ALT), CRP, and CRP/Alb ratio in the death group were significantly higher than those of the survival group, and the admission GCS score, platelet count (PLT), total bilirubin (TBil) and Alb were significantly lower than the survival group [WBC (×109/L): 14.80 (11.44, 17.15) vs. 11.96 (9.47, 14.82), NEU (×109/L): 13.05 (8.56, 15.67) vs. 9.50 (6.68, 12.09), AST (U/L): 108.00 (52.70, 291.50) vs. 64.50 (38.25, 110.50), ALT (U/L): 62.00 (19.50, 159.00) vs. 34.50 (20.75, 70.75), CRP (mg/L): 22.49 (3.42, 58.93) vs. 3.68 (1.01, 11.46), CRP/Alb ratio: 0.53 (0.08, 1.77) vs. 0.08 (0.02, 0.44), GCS score: 7.0 (5.0, 8.0) vs. 8.5 (7.0, 11.0), PLT (×109/L): 107.00 (73.50, 126.00) vs. 131.50 (107.50, 176.25), TBil (mmol/L): 15.60 (10.00, 25.30) vs. 21.40 (14.80, 30.05), Alb (g/L): 32.65 (32.53, 49.30) vs. 38.70 (36.20, 40.40), all P < 0.05]. Binary Logistic regression analysis showed that the GCS score [odds ratio (OR) = 0.686, 95% confidence interval (95%CI) was 0.491-0.959, P = 0.028], PLT (OR = 0.973, 95%CI was 0.954-0.992, P = 0.005), NEU (OR = 1.312, 95%CI was 1.072-1.606, P = 0.009) and CRP/Alb ratio (OR = 7.652, 95%CI was 1.632-35.881, P = 0.010) were independent influencing factors for 28-day mortality in HS patients. ROC curve analysis showed that the area under the curve (AUC) of GCS score, PLT, and CRP/Alb ratio for single prediction of 28-day prognosis in HS patients was 0.705, 0.752, and 0.729, and the combination of all three predicted the highest AUC of 28-day prognosis in HS patients (0.917), with a sensitivity and specificity of 86.2% and 81.2%, respectively.
CONCLUSION: CRP/Alb ratio, PLT, and GCS score are independent influencing factors affecting the prognosis of HS patients, and all of them have a certain predictive value for the prognosis of HS patients, in which the combination of the three has a higher predictive value for the prognosis of HS patients.
参考来源
- Shi S, Wu Z, Huang Y, et al. [Evaluation value of C-reactive protein/albumin ratio combined with platelet count and Glasgow coma scale for prognosis of patients with heat stroke]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40017364. doi:10.3760/cma.j.cn121430-20240607-00491
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。